Items where Author is "Laack, H-E"
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Other
Number of items: 1.
Other
Alt, J. and Bischoff, H. G. and Laack, H-E and Leistner, R. D. and Panse, J. and Reinmuth, N. and Schulz, C. and Grohe, C. (2018) A Phase 3, randomized study of first-line durvalumab (D) plus /- tremelimumab (T) plus platinum-based chemotherapy (CT) vs CT alone in extensive disease small-cell lung cancer (ED-SCLC): CASPIAN. KARGER, BASEL.
